retatrutide type 2 diabetes phase 2 results 2024 ada Lilly's triple agonist achieves 16.8% weight loss in 3 trial ADA Scientific Sessions highlight latest

The healthcare provider who prescribes you the medications should be available for regular check-in appointments to discuss your progress

In a clinical trial, people on tirzepatide experienced an average of 15% weight loss on 5 mg, 19% on 10 mg, and 21% on 15 mg

The skin barrier problem How this compares to prescription GLP-1 medicines GLP-1 patches vs weight loss injections Popular GLP-1 patch brands: what the reviews really tell you Are GLP-1 patches safe

Alcohol and Recreational Substances Alcohol slows gastric emptying independently

Kerr, Donghee Kim, Mazen Noureddin, Karn Wijarnpreecha Liver International .2026;[Epub] CrossRef Association of documented social deprivation with cardiovascular and liver outcomes in alcohol-associated liver disease Pojsakorn Danpanichkul, Yanfang Pang, Andrew F